Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Early microglia activation in a mouse model of chronic glaucoma.

The Journal of comparative neurology | 2011

Changes in microglial cell activation and distribution are associated with neuronal decline in the central nervous system (CNS), particularly under pathological conditions. Activated microglia converge on the initial site of axonal degeneration in human glaucoma, yet their part in its pathophysiology remains unresolved. To begin with, it is unknown whether microglia activation precedes or is a late consequence of retinal ganglion cell (RGC) neurodegeneration. Here we address this critical element in DBA/2J (D2) mice, an established model of chronic inherited glaucoma, using as a control the congenic substrain DBA/2J Gpnmb(+/SjJ) (D2G), which is not affected by glaucoma. We analyzed the spatial distribution and timecourse of microglial changes in the retina, as well as within the proximal optic nerve prior to and throughout ages when neurodegeneration has been reported. Exclusively in D2 mice, we detected early microglia clustering in the inner central retina and unmyelinated optic nerve regions, with microglia activation peaking by 3 months of age. Between 5 and 8 months of age, activated microglia persisted and concentrated in the optic disc, but also localized to the retinal periphery. Collectively, our findings suggest microglia activation is an early alteration in the retina and optic nerve in D2 glaucoma, potentially contributing to disease onset or progression. Ultimately, detection of microglial activation may have value in early disease diagnosis, while modulation of microglial responses may alter disease progression.

Pubmed ID: 21246546 RIS Download

Associated grants

  • Agency: NEI NIH HHS, United States
    Id: P30 EY014800
  • Agency: NEI NIH HHS, United States
    Id: P30 EY014800-07
  • Agency: NEI NIH HHS, United States
    Id: R01 EY020878
  • Agency: NEI NIH HHS, United States
    Id: T32 EY024234

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


AQP4 (C-19) (antibody)

RRID:AB_2059853

This polyclonal targets AQP4

View all literature mentions

CRALBP (antibody)

RRID:AB_2314227

This unknown targets

View all literature mentions

MAP1 (antibody)

RRID:AB_2314762

This unknown targets

View all literature mentions

Neurofilament Protein (antibody)

RRID:AB_2314899

This monoclonal targets Neurofilament isolated from normal adult human brain.

View all literature mentions

Brn-3 (C-13) (antibody)

RRID:AB_673441

This polyclonal targets POU4F2

View all literature mentions

Anti Iba1, Rabbit antibody (antibody)

RRID:AB_839504

This polyclonal targets Iba1

View all literature mentions